Jan. 23 at 4:46 PM
$INBS
Surprise, surprise.
INBS earned a spot on NASDAQ’s Threshold Security’s List. Wonder how.
Float just over 800k. Trading volumes with high volatility and even in the millions, and lots of chatter.
FTDs, high volatility, high short volume and a low float, few shares left (if any) and a high CTB rate in a company earning revenue, internationally positioned, awaiting a major milestone, means one thing.
NAKED SHORT SELLING.
Sure, dilution is coming. A growing company needs capital. Drug screening market is not a niche territory and worth billions.
Don’t sell your shares(and certainly don’t lend them). This company is not going bankrupt (but more likely will be bought out) so shares shorted will have to be covered someday, giving back the “smart money” you’ve made so far (or at least get investigated by the SEC).
